Physical activity (PA) program: The PA program is specific for each patient according to their mobility profile assessed using a decision tree comprising 3 tests: 1) the number of repetitions in the 30-second sit-to-stand test, 2) the score in the Short Physical Performance Battery (SPPB) test and 3) grip strength. The PA program has to be performed once daily.
Study summary
The aim of this study is to implement a simple and unsupervised home-based physical activity (PA) program for cancer patients in 2 oncogeriatric units in Toulouse Hospital (day hospital and week hospital).
Eligibility
Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
inclusion criteria:
* suffering from a hematological malignancy (Myelodysplasia, Leukemia of any type, Lymphoma, Myeloma)
* patient affiliated to a social security insurance
* Patient undergoing or scheduled chemotherapy (\< 3 months) and/or immunotherapy and/or targeted therapy.
Exclusion criteria:
* Life expectancy estimated at less than 3 months by the unit doctor;
* Cognitive impairment (not allowing comprehension of the physical activity program and research project) defined by Mini-Mental State Examination (MMSE) \<20/30;
* Patient included in a clinical trial that potentially interferes with the study objective (geriatric interventional study, early drug study, study modifying the patient's lifestyle habits).;
* Acute health problem (fever, severe anemia, intense pain, etc.) limiting the possibility of involvement in the program;
* Contraindication to physical activity;
* Patient under legal protection (guardianship or curatorship or safeguard of justice);
* Refusal of patient or primary caregiver to participate.
Primary outcome measure(s)
Feasibility of the PA program — 6 months PA program is considered feasible if at least 50% of them complete at least 70% of the prescribed sessions. Adherence is recorded in a logbook (every day), during the usual follow-up at the hospital (every month) and during telephone follow-up (weeks 1, 2, 4, 6, 9, 12, 16, 20, et 24).
Trial sites (1)
Facility
City
Region
Status
Chu de Toulouse
Toulouse
France
More University Hospital, Toulouse trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
